Episode 16: More results — Wisetech, BWX, Kip McGrath & more, plus is Australia headed for recession?

But is the market over-reacting?

Aerial imaging specialist Nearmap (ASX:NEA) today revealed the launch of its latest products: Nearmap 3D and the beta version of its Artificial Intelligence (AI) product. Both have the potential to further consolidate Nearmap’s industry leadership position. But let’s take a step back. What exactly does Nearmap do? Google maps on steroids Founded in 2007 in Perth, Nearmap has grown from […]

This time last year, the big names in finance were practically shrugging at the Aussie market’s prospects for 2024. AMP predicted a modest 4% gain, with the RBA supposedly cutting rates from 4.35% to 3.6% to keep things afloat. UBS said the ASX200 would end the year right where it started. ANZ forecasted “mid-single-digit returns with risks skewed to the downside.” […]

Kiwi breast imaging software specialist Volpara (ASX:VHT) has confirmed it is on track to meet its target for NZ$17.1 million in annual recurring revenue (ARR) for the 2020 financial year. That compares with an ARR of NZ$6.6 million in the previous year, with the recent acquisition of MRS Systems expected to contribute around NZ$6.7 million to the total. At the […]

. Businesses that enjoy network effects tend to have a much greater capacity to deliver outsized returns. They aren’t especially common, but if you can find them you stand to do extremely well — even if it often feels like you are too late. At its core, a network effect describes a situation where the value of a product or service increases exponentially […]

With a grossed up yield of 8.4%, could this be an attractive opportunity for income investors?

“10-baggers” — stocks that appreciate ten-fold in value — are the stuff of dreams. Especially when the gains are delivered in a relatively short space of time. Sure, they don’t come around too often, but they’re perhaps not as rare as you might think: according to S&P, there have been no less than 52 stocks on the ASX that have […]

Andrew reviews his public scorecard, Matt surveys the macro landscape and Claude talks about the perils (and opportunities) of investing in micro-caps.